EGM
RVLP

Engineers Gate Manager’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Engineers Gate Manager’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-21,870
Closed -$30K – 2191
2022
Q2 		$30K Sell
21,870
-5,318
-20% -$7.7K ﹤0.01% 1810
2022
Q1 		$46K Sell
27,188
-15,622
-36% -$22.3K ﹤0.01% 1756
2021
Q4 		$46K Buy
42,810
+16,890
+65% +$27.4K ﹤0.01% 1877
2021
Q3 		$76K Sell
25,920
-8,938
-26% -$30K ﹤0.01% 1558
2021
Q2 		$105K Sell
34,858
-25,560
-42% -$78.2K 0.01% 1494
2021
Q1 		$197K Sell
60,418
-33,960
-36% -$140K 0.01% 1606
2020
Q4 		$389K Buy
94,378
+21,689
+30% +$125K 0.02% 1137
2020
Q3 		$393K Buy
72,689
+13,570
+23% +$78.2K 0.02% 1113
2020
Q2 		$398K Buy
59,119
+17,937
+44% +$87.8K 0.02% 1072
2020
Q1 		$131K Buy
41,182
+8,679
+27% +$46.2K 0.01% 1360
2019
Q4 		$227K Buy
+32,503
New +$173K 0.01% 1411

Other funds holding RVLP

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
RA
Rovida Advisors Fort Lauderdale, Florida $116M AUM 12.52% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Engineers Gate Manager's RVLP Position: Q3 2022 in Review

Engineers Gate Manager sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q3 2022, closing a stake of 21,870 shares — an estimated $30K sold.

Engineers Gate Manager first reported a position in RVLP in Q4 2019 and held it in 11 quarters. The position peaked at $398K in Q2 2020. 46 funds tracked by Wall St. Rank hold RVLP as of Q3 2022.

  • Engineers Gate Manager reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q3 2022 after selling out during the quarter.
  • Engineers Gate Manager sold 21,870 RVL Pharmaceuticals plc Ordinary Shares shares in Q3 2022, an estimated $30K.
  • Engineers Gate Manager first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q4 2019 and held it in 11 quarters.
  • Engineers Gate Manager's RVL Pharmaceuticals plc Ordinary Shares position peaked at $398K in Q2 2020.
  • 46 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q3 2022.

Based on Engineers Gate Manager's 13F filing for Q3 2022, filed 14 Nov 2022.